Free tool
FAERS Monitor: Voquezna Triple Pak
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215152 or its brand name (Voquezna Triple Pak, Amoxicillin, Clarithromycin, Vonoprazan Fumarate). Reports on generic versions are filed under their own applications.
Reports
41
Serious
4
10% of reports
Hospitalization
3
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea6
- headache6
- dysgeusia5
- nausea5
- abdominal discomfort4
- chest discomfort3
- drug ineffective3
- dyspepsia3
- fatigue3
- off label use3
- pain3
- palpitations3
- abdominal distension2
- chills2
- cough2
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2024 | 7 |
| 2025 | 14 |
| 2026 | 20 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,118 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dysgeusiaSignal | 5 | 34.5 | 15.2 | 131 |
| dyspepsiaSignal | 3 | 15.6 | 5.3 | 28 |
| chest discomfortSignal | 3 | 15.0 | 5.1 | 27 |
| palpitationsSignal | 3 | 13.1 | 4.4 | 23 |
| abdominal discomfortSignal | 4 | 12.2 | 4.8 | 31 |
| abdominal distension | 2 | 9.8 | 2.5 | 8 |
| chills | 2 | 8.8 | 2.3 | 7 |
| headacheSignal | 6 | 4.9 | 2.3 | 15 |
| diarrhoeaSignal | 6 | 4.8 | 2.3 | 15 |
| cough | 2 | 3.7 | 0.9 | 2 |
| nauseaSignal | 5 | 3.2 | 1.4 | 6 |
| pain | 3 | 2.5 | 0.8 | 1 |
| fatigue | 3 | 2.0 | 0.7 | 1 |
| off label use | 3 | 1.8 | 0.6 | 0 |
| drug ineffective | 3 | 1.2 | 0.4 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.